Antibiotic resistance in Helicobacter pylori infection

British Medical Bulletin

Volumn 54, Issue 1, 1998, Pages 207-216

  Mégraud, Francis ^a  

^a HÔPITAL PELLEGRIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BISMUTH DERIVATIVE; CIPROFLOXACIN; CLARITHROMYCIN; MACROLIDE; METRONIDAZOLE; NITROIMIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RANITIDINE BISMUTH CITRATE; RNA 23S; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ERADICATION THERAPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; NONHUMAN; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; POINT MUTATION; PRIORITY JOURNAL; REVIEW; RIBOSOME;

EID: 1042284860     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.bmb.a011671     Document Type: Review

References (24)

1. Van der Hulst RWM, Keller JJ, Rauws EAJ et al. Treatment of Helicobacter pylori infection: a review of the world literature. Helicobacter 1996; 1: 6-19
2. Mégraud F. Resistance of Helicobacter pylori to antibiotics. Aliment Pharmacol Ther 1997; 11 (Suppl 1): 43-53
3. Occhialini A, Urdaci M, Doucet-Populaire F et al. Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosomes. Antimicrob Agents Chemother 1997; 41: 2724-8
4. Versalovic J, Shortridge D, Kibler K et al. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother 1996; 40: 477-80
5. Debets-Ossenkopp YJ, Sparrius M, Kusters JG et al. Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori. FEMS Microbiol Lett 1996; 142: 37-42
6. Szczebara F, Dhaenens L, Vincent P et al. Evaluation of rapid molecular detection of clarithromycin resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1997; 16: 162-4
7. Stone GG, Shortridge D, Versalovic J et al. A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori. Antimicrob Agents Chemother 1997; 41: 712-4
8. Pina M, Occhialini A, Monteiro L et al. Rapid detection of point mutations associated with macrolide resistance in Helicobacter pylori using the Gen-eti-k DEIA hybridization kit. Gut 1997; 41(Suppl 1): A75
9. Smith MA, Edwards DI. The influence of microaerophilia and anaerobiosis on metronidazole uptake in Helicobacter pylori. J Antimicrob Chemother 1995; 36: 453-61
10. Cederbrant G, Kahlmeter G, Ljungh A. Proposed mechanism for metronidazole resistance in Helicobacter pylori. J Antimicrob Chemother 1992; 29: 115-20
11. Smith MA, Edwards DI. Redox potential and oxygen concentration as factors in the susceptibility of Helicobacter pylori to nitroheterocyclic drugs. J Antimicrob Chemother 1995; 35: 751-64
12. Van Zwet AA, Thijs JC, de Graaf B. Explanations for high rates of eradication with triple therapy using metronidazole in patients harboring metronidazole-resistant Helicobacter pylori strains. Antimicrob Agents Chemother 1995; 39: 250-2
13. Hoffman PS, Goodwin A, Johnsen et al. Metabolic activities of metronidazole-sensitive and -resistant strains of Helicobacter pylori: repression of pyruvate oxidoreductase and expression of isocitrate lyase activity correlate with resistance. J Bacteriol 1996; 178: 4822-9
14. Moore RA, Beckthold B, Wong S et al. Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori. Antimicrob Agents Chemother 1995; 39: 107-11
15. Midolo PD, Korman MG, Turnbridge JD et al. Helicobacter pylori resistance to tetracycline. Lancet 1996; 347: 1194-5
16. Dore MP, Sepulveda AR, Mura I et al. Explanation for variability of omeprazole-amoxicillin therapy? Tolerance of H. pylori to amoxicillin. Gastroenterology 1997; 112: A105
17. de Koster E, Cozzoli A, Vandenborre C et al. H. pylori resistance to macrolides increases, to imidazoles remains stable. Gastroenterology 1997; 112: A99
18. Glupczynski Y, the European Study Group on Antibiotic Susceptibility of H. pylori. Results of a multicentre European survey in 1991 of metronidazole resistance in H. pylori. Eur J Clin Microbiol Infect Dis 1992; 11: 777-81
19. Bouchard S, Birac C, Lamouliatte H et al. Correlation between the MICS of metronidazole on H. pylori strains and the outcome of a lansoprazole-amoxicilline-metronidazole therapy. Gut 1996; 39 (Suppl 2): 1A05
20. Malfertheiner P, Mégraud F, O'Morain C et al. Current European concepts in the management of Helicobacter pylori infection - the Maastricht consensus report. Eur J Gastroenterol Hepatol 1997; 9: 1-2
21. Wurzer H, Rodrigo L, Stamler D et al. Short-course therapy with amoxicillin-clarithromycin triple for 10 days (ACT-10) eradicates H. pylori and heals duodenal ulcer. Aliment Pharmacol Ther 1997; 11: 943-52
22. Mégraud F, Lehn N, Lind T et al. The MACH 2 study. Helicobacter pylori resistance to antimicrobiol agents and its influence on clinical outcome. Gastroenterology 1997; 112: A216
23. de Boer W, Driessen W, Jansz A et al. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995; 345: 817-20
24. Savarino, Mansi C, Mele MR et al. A new one-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus two antibiotics. Aliment Pharmacol Ther 1997; 11: 247-51